Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Ruxolitinib can help regrow hair in severe alopecia areata.

Deleting TNFα gene reduces skin cancer risk in certain mice.

A faulty KLHL24 gene leads to hair loss by damaging hair follicle stem cells.

A new mutation in the ST14 gene broadens the understanding of ichthyosis-hypotrichosis syndrome.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A specific gene mutation causes a severe skin disorder in a family.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

Consider Sertoli-Leydig cell tumors in Peutz-Jeghers syndrome patients with adnexal masses.

Patients with alopecia areata using Janus kinase inhibitors are not following lab monitoring guidelines.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

A mutation in the KRT86 gene causes hair fragility in a Turkish family.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

A boy with Oculodentodigital syndrome had a unique GJA1 gene mutation causing his symptoms.

Keratins are crucial for tissue strength, and mutations in keratin genes can lead to various diseases, highlighting the need for targeted therapies.

The Lanceolate hair-J mutation in mice mimics human hair disorders like Netherton's syndrome.

Understanding genetics is crucial for treating heart and skin diseases.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.